Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)
China
· Delayed Price · Currency is CNY 27.70
+0.19 (0.69%)
Jun 16, 2025, 2:45 PM CST
SHA:600566 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 13, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 25,540 | 26,803 | 28,972 | 25,092 | 25,173 | 17,969 | Upgrade
|
| Market Cap Growth | -25.74% | -7.49% | 15.47% | -0.32% | 40.09% | -8.81% | Upgrade
|
| Enterprise Value | 13,677 | 16,353 | 19,711 | 18,865 | 20,556 | 14,633 | Upgrade
|
| Last Close Price | 27.71 | 29.08 | 30.31 | 25.46 | 25.74 | 17.94 | Upgrade
|
| PE Ratio | 11.95 | 10.59 | 10.26 | 11.56 | 14.64 | 14.07 | Upgrade
|
| Forward PE | 11.84 | 8.82 | 11.02 | 11.16 | 7.47 | 11.87 | Upgrade
|
| PS Ratio | 3.58 | 3.34 | 3.00 | 2.79 | 3.30 | 2.92 | Upgrade
|
| PB Ratio | 1.68 | 1.82 | 2.17 | 2.21 | 2.76 | 2.32 | Upgrade
|
| P/TBV Ratio | 1.74 | 1.88 | 2.25 | 2.31 | 2.90 | 2.46 | Upgrade
|
| P/FCF Ratio | 16.83 | 13.39 | 9.16 | 10.56 | 15.29 | 13.29 | Upgrade
|
| P/OCF Ratio | 15.65 | 12.32 | 8.36 | 9.57 | 13.29 | 10.09 | Upgrade
|
| PEG Ratio | - | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | Upgrade
|
| EV/Sales Ratio | 1.92 | 2.04 | 2.04 | 2.10 | 2.69 | 2.37 | Upgrade
|
| EV/EBITDA Ratio | 5.70 | 6.00 | 6.19 | 7.37 | 10.47 | 8.78 | Upgrade
|
| EV/EBIT Ratio | 6.52 | 6.74 | 6.84 | 8.37 | 12.31 | 10.56 | Upgrade
|
| EV/FCF Ratio | 9.01 | 8.17 | 6.23 | 7.94 | 12.49 | 10.82 | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.06 | 0.08 | 0.04 | 0.07 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 0.29 | 0.31 | 0.34 | 0.16 | 0.32 | 0.36 | Upgrade
|
| Debt / FCF Ratio | 0.46 | 0.42 | 0.35 | 0.17 | 0.38 | 0.45 | Upgrade
|
| Asset Turnover | 0.38 | 0.44 | 0.58 | 0.66 | 0.67 | 0.64 | Upgrade
|
| Inventory Turnover | 3.03 | 3.15 | 4.05 | 4.01 | 3.90 | 3.66 | Upgrade
|
| Quick Ratio | 4.77 | 3.99 | 2.99 | 3.13 | 2.75 | 3.18 | Upgrade
|
| Current Ratio | 4.93 | 4.16 | 3.10 | 3.26 | 2.90 | 3.34 | Upgrade
|
| Return on Equity (ROE) | 14.51% | 18.06% | 22.87% | 21.20% | 20.33% | 18.42% | Upgrade
|
| Return on Assets (ROA) | 6.95% | 8.28% | 10.88% | 10.39% | 9.22% | 9.03% | Upgrade
|
| Return on Capital (ROIC) | 8.25% | 10.10% | 13.75% | 13.10% | 11.52% | 11.51% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.60% | 16.30% | 21.30% | 19.50% | 17.90% | 16.20% | Upgrade
|
| Earnings Yield | 8.33% | 9.45% | 9.74% | 8.65% | 6.83% | 7.11% | Upgrade
|
| FCF Yield | 5.94% | 7.47% | 10.91% | 9.47% | 6.54% | 7.52% | Upgrade
|
| Dividend Yield | 7.60% | 7.19% | 4.29% | 3.46% | 2.64% | 2.51% | Upgrade
|
| Payout Ratio | 57.03% | 48.10% | 29.16% | 27.89% | 23.81% | 78.98% | Upgrade
|
| Buyback Yield / Dilution | 0.04% | -0.08% | -0.91% | -0.91% | -7.82% | -2.36% | Upgrade
|
| Total Shareholder Return | 7.64% | 7.11% | 3.38% | 2.55% | -5.18% | 0.15% | Upgrade
|
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.